Indegene Ltd
Indegene Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #20 of 33 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Indegene Ltd Q2 FY27 key numbers
- Revenue
- Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY.
As stated in Indegene Ltd's Q2 FY27 investor presentation · published 29 Oct 2026. Reported figures, not investment advice.
Based on Indegene Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) - Revenue in USD for Q2 FY27: $117.5 million, up 27.5% YoY (Page 23, 15, 4) - Active clients increased to 107 fro EBITDA: ₹1,873 million for Q2 FY27, up 32.0% YoY; EBITDA margin at 16.7%, down 1.0 percentage point YoY.
From Indegene Ltd's Q2 FY27 earnings-call transcript · updated 29 Oct 2026.
Revenue & Sales Performance
- Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4)
- Revenue in USD for Q2 FY27: $117.5 million, up 27.5% YoY (Page 23, 15, 4)
- Active clients increased to 107 from 72 YoY, a 40.8% rise (Page 23, 8)
- Revenue per employee grew 15.5% YoY to $79.6K (Page 23, 8)
2 more points from Indegene Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Indegene Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Indegene Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Indegene Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Indegene Ltd said on order book & pipeline — free account, 30 seconds.
Indegene Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.1K Cr, net profit ₹112 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Indegene Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio
- Aatmaj Healthcare Ltd (Q2 FY27)
Revenue from operations for H1 FY 26-27: ₹1,695.98 million vs ₹1,081.04 million in H1 FY 25-26, reflecting a 54% growth (Page 13 & 14). Key investor presentatio
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Indegene Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Indegene Ltd Q2 FY27 results?
Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) - Revenue in USD for Q2 FY27: $117.5 million, up 27.5% YoY (Page 23, 15, 4) - Active clients increased to 107 fro EBITDA: ₹1,873 million for Q2 FY27, up 32.0% YoY; EBITDA margin at 16.7%, down 1.0 percentage point YoY.
What is Indegene Ltd share price analysis?
Indegene Ltd currently shows a neutral. The stock trades at a P/E of 34.4 with a market cap of ₹14,305 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Indegene Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.